Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reiss

Showing results (131-140 of 269) with videos related to

Pageof 27
Sort By:
The Oncologist|May 13, 2022
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal CancerThomas B Karasic, Timothy J Brown, Charles Schneider, et al.
Genetic Testing|March 21, 2006
Predictors of belief that genetic test information about hemochromatosis should be shared with family membersDiane C Tucker, Ronald T Acton, Nancy Press, et al.
Journal of Genetic Counseling|March 19, 2017
Reasons for Declining Preconception Expanded Carrier Screening Using Genome SequencingMarian J Gilmore, Jennifer Schneider, James V Davis, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2020
Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control studyAkram Saad, Jeffrey Goldstein, Ofer Margalit, et al.
Oncotarget|November 4, 2021
THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinomaPhyllis A Gimotty, Jacob E Till, Shirsa Udgata, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 17, 2015
Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitatorsJennifer L Schneider, James Davis, Tia L Kauffman, et al.
Cancer|June 4, 2015
Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriersJessica Ezzell Hunter, Jamilyn M Zepp, Mari J Gilmore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2023
The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on RucaparibTimothy J Brown, Arielle Yablonovitch, Jacob E Till, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2008
Accuracy of family history of hemochromatosis or iron overload: the hemochromatosis and iron overload screening studyRonald T Acton, James C Barton, Leah V Passmore, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 26, 2005
Concerns in a primary care population about genetic discrimination by insurersMark A Hall, Jean E McEwen, James C Barton, et al.
Pageof 27

Showing results (131-140 of 269) with videos related to

Sort By:
Pageof 27
The Oncologist|May 13, 2022
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal CancerThomas B Karasic, Timothy J Brown, Charles Schneider, et al.
Genetic Testing|March 21, 2006
Predictors of belief that genetic test information about hemochromatosis should be shared with family membersDiane C Tucker, Ronald T Acton, Nancy Press, et al.
Journal of Genetic Counseling|March 19, 2017
Reasons for Declining Preconception Expanded Carrier Screening Using Genome SequencingMarian J Gilmore, Jennifer Schneider, James V Davis, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2020
Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control studyAkram Saad, Jeffrey Goldstein, Ofer Margalit, et al.
Oncotarget|November 4, 2021
THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinomaPhyllis A Gimotty, Jacob E Till, Shirsa Udgata, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 17, 2015
Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitatorsJennifer L Schneider, James Davis, Tia L Kauffman, et al.
Cancer|June 4, 2015
Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriersJessica Ezzell Hunter, Jamilyn M Zepp, Mari J Gilmore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2023
The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on RucaparibTimothy J Brown, Arielle Yablonovitch, Jacob E Till, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2008
Accuracy of family history of hemochromatosis or iron overload: the hemochromatosis and iron overload screening studyRonald T Acton, James C Barton, Leah V Passmore, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 26, 2005
Concerns in a primary care population about genetic discrimination by insurersMark A Hall, Jean E McEwen, James C Barton, et al.
Pageof 27